Show simple item record

dc.contributor.authorErgenc, N
dc.contributor.authorDemirdamar, R
dc.contributor.authorGunay, NS
dc.date.accessioned2021-03-03T18:01:11Z
dc.date.available2021-03-03T18:01:11Z
dc.date.issued1998
dc.identifier.citationErgenc N., Gunay N., Demirdamar R., "Synthesis and antidepressant evaluation of new 3-phenyl-5-sulfonamidoindole derivatives", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, cilt.33, sa.2, ss.143-148, 1998
dc.identifier.issn0223-5234
dc.identifier.otherav_4cc744ac-eed8-45b0-8b84-0af6ec8de1d9
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/54960
dc.identifier.urihttps://doi.org/10.1016/s0223-5234(98)80039-1
dc.description.abstractTen new arylidenehydrazides were synthesized by reacting 3-phenyl-5-sulfonamidoindol-2-carboxylic acid hydrazide with various aldehydes and a new N-2-substituted hydrazide was prepared by reduction of 3-phenyl-5-sulfonamidoindole-2-carboxylic acid benzylidene-hydrazide 2 with sodium borohydride. The chemical structures of the compounds were verified by means of their IR, H-1-NMR, E1 mass spectroscopic data and elemental analyses. The antidepressant activity of these compounds were evaluated by the Porsolt forced swimming (behavioral despair) test using tranylcypromine as the standard. 3-Phenyl-5-sulfonamidoindole-2-carboxylic acid 3,4-methylenedioxybenzylidenehydrazide, 3-phenyl-5-sulfonamidoindole-2-carboxylic acid 4-methylbenzylidene- hydrazide, 3-phenyl-5-sulfonamidoindole-2-carboxylic acid 4-nitrobenzylidenehydrazide and 3-phenyl-5-sulfonamidoindole-2-carboxylic acid benzylidenehydrazide showed antidepressant activity at 100 mg/kg. (C) Elsevier, Paris.
dc.language.isoeng
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectBiyokimya
dc.subjectTemel Bilimler
dc.subjectSağlık Bilimleri
dc.subjectEczacılık
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectTemel Bilimler (SCI)
dc.subjectKimya
dc.subjectKİMYA, TIP
dc.titleSynthesis and antidepressant evaluation of new 3-phenyl-5-sulfonamidoindole derivatives
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
dc.contributor.department, ,
dc.identifier.volume33
dc.identifier.issue2
dc.identifier.startpage143
dc.identifier.endpage148
dc.contributor.firstauthorID120491


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record